297142-55-3Relevant academic research and scientific papers
MAGL inhibitor, preparation method and application
-
Paragraph 0015-0018, (2020/08/30)
The invention belongs to the field of medicines, and relates to a compound and a pharmaceutically acceptable salt thereof, a preparation method thereof, a composition containing the compound or the salt, and their use for the treatment of MAGL-mediated diseases and disorders (including, for example, pain, inflammatory disorders, traumatic brain injury, depression, anxiety, Alzheimer's disease, metabolic disorders, stroke or cancer, etc).
Synthesis, characterization and biological activity of 5-arylidene-3-(6,7-dicloro-1,3-benzothiazol-2-yl)-phenyl-3,5-dihydro-4H-imidazol-4-ones
Baldaniya
scheme or table, p. 81 - 84 (2011/01/03)
Some novel 5-arylidene-3-(6,7-dichloro-1,3-benzothiazol-2-yl)-2-phenyl-3,5-dihydro-4H-imidazol-4-ones (6a-q) have been synthesized and characterized by elemental analyses, IR, NMR, and mass spectra. The products have been evaluated for antibacterial and a
